[#item_full_content] “That may apply not only to Parkinson’s, but also neuropsychiatric disorders like depression and anxiety.” By Noah Daly, Psychedelic State(s) of America For years, researchers have been exploring how psychedelics can address inflammation. When psychedelics enter the brain, they clump onto serotonin receptors. This has made them such interesting candidates for treating mental health conditions, 
Read More
Psilocybin Reduces Inflammation And Mitochondrial Stress Markers In People With Parkinson’s Disease, Study Shows
ByPot Shop News
October 26, 2026